232 related articles for article (PubMed ID: 24705316)
1. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
2. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
3. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
4. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
5. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
[TBL] [Abstract][Full Text] [Related]
6. SNP array and FISH findings in two pleomorphic hyalinizing angiectatic tumors.
Mohajeri A; Kindblom LG; Sumathi VP; Brosjö O; Magnusson L; Nilsson J; Nord KH; Mertens F
Cancer Genet; 2012 Dec; 205(12):673-6. PubMed ID: 23177593
[TBL] [Abstract][Full Text] [Related]
7. Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor.
Rougemont AL; Berczy M; Lin Marq N; McKee TA; Christinat Y
Virchows Arch; 2019 Aug; 475(2):251-254. PubMed ID: 30911815
[TBL] [Abstract][Full Text] [Related]
8. Rapidly fatal SMARCA4-deficient undifferentiated sarcoma originating from hybrid hemosiderotic fibrolipomatous tumor/pleomorphic hyalinizing angiectatic tumor of the foot.
Agaimy A; Meidenbauer N; Sukov WR; Stoehr R; Vieth M; Roemer F; Grützmann R; Folpe AL
Virchows Arch; 2022 May; 480(5):1115-1120. PubMed ID: 34389899
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
10. Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma: Related or Not?
Boland JM; Folpe AL
Adv Anat Pathol; 2017 Sep; 24(5):268-277. PubMed ID: 28375867
[TBL] [Abstract][Full Text] [Related]
11. Novel Cytogenetic Characterization of Pleomorphic Hyalinizing Angiectatic Tumor (PHAT).
Rankins C; Covington JD; Devitt K; Kalof A; Goetz R; Gardner JA
J Assoc Genet Technol; 2019; 45(3):116-120. PubMed ID: 31554742
[TBL] [Abstract][Full Text] [Related]
12. Cytologic and Histologic Features of Pleomorphic Undifferentiated Sarcoma Arising in a Hybrid Hemosiderotic Fibrolipomatous Tumor and Pleomorphic Hyalinizing Angiectatic Tumor: Report of an Unusual Case with a Literature Review.
Morency E; Laskin W; Lin X
Acta Cytol; 2015; 59(6):493-7. PubMed ID: 26841226
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic hyalinizing angiectatic tumor of soft parts: case report with unusual ganglion-like cells and review of the literature.
Changchien YC; Bocskai P; Kovács I; Hargitai Z; Kollár S; Török M
Pathol Res Pract; 2014 Dec; 210(12):1146-51. PubMed ID: 24857338
[TBL] [Abstract][Full Text] [Related]
14. Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates.
Ieremia E; Thway K
Arch Pathol Lab Med; 2014 Oct; 138(10):1406-11. PubMed ID: 25268202
[TBL] [Abstract][Full Text] [Related]
15. Deep sequencing of myxoinflammatory fibroblastic sarcoma.
Arbajian E; Hofvander J; Magnusson L; Mertens F
Genes Chromosomes Cancer; 2020 May; 59(5):309-317. PubMed ID: 31898851
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic hyalinizing angiectatic tumor: analysis of 41 cases supporting evolution from a distinctive precursor lesion.
Folpe AL; Weiss SW
Am J Surg Pathol; 2004 Nov; 28(11):1417-25. PubMed ID: 15489645
[TBL] [Abstract][Full Text] [Related]
17. Pleomorphic Hyalinizing Angiectatic Tumor (PHAT): Review of the Literature with Case Presentation.
Cazzato G; Colagrande A; Cimmino A; Lettini T; Savino MT; Martella C; Ingravallo G; Resta L
Dermatopathology (Basel); 2021 Apr; 8(2):97-102. PubMed ID: 33916538
[TBL] [Abstract][Full Text] [Related]
18. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.
Michal M; Kazakov DV; Hadravský L; Kinkor Z; Kuroda N; Michal M
Ann Diagn Pathol; 2015 Jun; 19(3):157-63. PubMed ID: 25886867
[TBL] [Abstract][Full Text] [Related]
19. Synovial Sarcoma Mimicking Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts: A Case Report.
Gupta N; Kenan S; Kahn LB
Int J Surg Pathol; 2018 Feb; 26(1):73-77. PubMed ID: 28764610
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features of pleomorphic hyalinizing angiectatic tumor of soft parts.
Ke Q; Erbolat ; Zhang HY; Bu H; Li S; Shi DN; Yang GH; Chen HJ; Wei B
Chin Med J (Engl); 2007 May; 120(10):876-81. PubMed ID: 17571460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
